Wolverine Trading’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.31M Buy
496,200
+100
+0% +$926 ﹤0.01% 1498
2025
Q2
$4.74M Buy
496,100
+98,800
+25% +$872K ﹤0.01% 1090
2025
Q1
$4.23M Buy
397,300
+41,100
+12% +$414K ﹤0.01% 1081
2024
Q4
$3.33M Buy
356,200
+229,900
+182% +$2.33M ﹤0.01% 1510
2024
Q3
$1.41M Buy
+126,300
New +$1.34M ﹤0.01% 2027
2022
Q4
Sell
-17,600
Closed -$336K 3879
2022
Q3
$336K Buy
+17,600
New +$362K ﹤0.01% 3035
2021
Q2
Sell
-6,700
Closed -$233K 5789
2021
Q1
$233K Buy
+6,700
New +$237K ﹤0.01% 4834

Other funds holding AHCO

Wolverine Trading's AHCO Position: Q3 2025 in Review

Wolverine Trading increased its AdaptHealth (AHCO) stake by 48% in Q3 2025, buying an estimated $533K and bringing the position to 176,831 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Wolverine Trading first reported a position in AHCO in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.56M in Q1 2025. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • Wolverine Trading held 176,831 shares of AdaptHealth worth $1.53M as of Q3 2025.
  • Wolverine Trading bought 57,554 AdaptHealth shares in Q3 2025, an estimated $533K.
  • AdaptHealth made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2449 holding.
  • Wolverine Trading first reported a position in AdaptHealth in Q3 2022 and has held it in 6 quarters since.
  • Wolverine Trading's AdaptHealth position peaked at $1.56M in Q1 2025.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.